Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 17 Jul 24 EFFECT Notice of effectiveness
- 11 Jul 24 POS AM Prospectus update (post-effective amendment)
- 8 Dec 23 424B4 Prospectus supplement with pricing info
- 7 Dec 23 EFFECT Notice of effectiveness
-
6 Dec 23 S-1/A IPO registration (amended)
- 4 Dec 23 S-1/A IPO registration (amended)
- 21 Nov 23 S-1/A IPO registration (amended)
- 3 Nov 23 S-1 IPO registration
ZVSA similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 31, 2023 (except for the effects of the reverse stock split discussed in Note 14, as to which the date is December 4, 2023) in Amendment No. 3 to the Registration Statement (Form S-1 No. 333-275320) and the related Prospectus of ZyVersa Therapeutics, Inc. for the registration of shares of its common stock.
/s/ Ernst & Young LLP
Orlando, Florida
December 6, 2023